Skip to content
10-Q

Quarterly Report

BIOREGENX, INC. BRGX

0001683168-24-008044

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 14, 2024 956.53M sh
Cash And Equivalents Q3 2024 · Sep 30, 2024 $70.08K
Cash And Equivalents Q3 2024 · Dec 31, 2023 $125.4K
Current Liabilities Q3 2024 · Sep 30, 2024 $3.52M
Current Liabilities Q3 2024 · Dec 31, 2023 $2.79M
Total Liabilities Q3 2024 · Sep 30, 2024 $3.8M
Total Liabilities Q3 2024 · Dec 31, 2023 $2.94M
Current Assets Q3 2024 · Sep 30, 2024 $371.04K
Current Assets Q3 2024 · Dec 31, 2023 $652.66K
Total Assets Q3 2024 · Sep 30, 2024 $17.36M
Total Assets Q3 2024 · Dec 31, 2023 $865.75K
Shares Diluted restated Q3 2024 · Sep 30, 2023 621.92M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 620.76M sh
Capex Q3 2024 · Sep 30, 2023 $0
Operating Cash Flow restated Q3 2024 · Sep 30, 2023 −$1.27M
Stockholders Equity restated Q3 2024 · Sep 30, 2023 −$2.8M
Stockholders Equity restated Q3 2024 · Jun 30, 2023 −$2.58M
Stockholders Equity restated Q3 2024 · Dec 31, 2022 −$2.53M
Eps Diluted Q3 2024 · Sep 30, 2023 $0.00
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$0.01
Eps Basic Q3 2024 · Sep 30, 2023 $0.00
Eps Basic restated Q3 2024 · Sep 30, 2023 −$0.01
Sga Expense Q3 2024 · Sep 30, 2023 $2.96M
Sga Expense Q3 2024 · Sep 30, 2023 $4.73M
Rd Expense Q3 2024 · Sep 30, 2023 $80.78K
Rd Expense Q3 2024 · Sep 30, 2023 $175.07K
Net Income restated Q3 2024 · Sep 30, 2023 −$2.52M
Net Income restated Q3 2024 · Sep 30, 2023 −$3.34M
Operating Income restated Q3 2024 · Sep 30, 2023 −$2.47M
Operating Income restated Q3 2024 · Sep 30, 2023 −$3.2M
Gross Profit Q3 2024 · Sep 30, 2023 $571.2K
Gross Profit Q3 2024 · Sep 30, 2023 $1.93M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $223.34K
Cost Of Revenue Q3 2024 · Sep 30, 2023 $800K
Revenue restated Q3 2024 · Sep 30, 2023 $794.54K
Revenue restated Q3 2024 · Sep 30, 2023 $2.73M